Related Experiment Video
Updated: Apr 22, 2026

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
17.5K
Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate
Y M Lau1, Y K Lam1, K H Leung1
1Department of Medicine and Geriatrics, United Christian Hospital, Kwun Tong, Hong Kong.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|October 14, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Targeted Cancer Therapies
6.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
6.9K
Chronic Kidney Disease II: Clinical Manifestations
1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K

